Minerva Surgical, Inc.Minerva Surgical, Inc.Minerva Surgical, Inc.

Minerva Surgical, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪8.88 K‬USD
−23.7052USD
‪−34.11 M‬USD
‪50.29 M‬USD
‪40.58 K‬
Beta (1Y)
−0.82

About Minerva Surgical, Inc.

CEO
Todd Usen
Headquarters
Santa Clara
Employees (FY)
174
Founded
2008
FIGI
BBG012QFWLD6
Minerva Surgical, Inc. engages in the research, development, manufacture, and commercialization of invasive solutions for uterine healthcare needs of women. It offers therapeutic devices for abnormal uterine bleeding treatment. The company was founded by Csaba Truckai in 2008 and is headquartered in Santa Clara, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of UTRS is 0.0010 USD — it hasn't changed in the past 24 hours. Watch Minerva Surgical, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Minerva Surgical, Inc. stocks are traded under the ticker UTRS.
Minerva Surgical, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
UTRS stock is 0% volatile and has beta coefficient of −0.82. Track Minerva Surgical, Inc. stock price on the chart and check out the list of the most volatile stocks — is Minerva Surgical, Inc. there?
Yes, you can track Minerva Surgical, Inc. financials in yearly and quarterly reports right on TradingView.
UTRS stock hasn't changed in a week, the month change is a 99.80% fall, over the last year Minerva Surgical, Inc. has showed a 99.98% decrease.
UTRS net income for the last quarter is ‪−7.18 M‬ USD, while the quarter before that showed ‪−8.68 M‬ USD of net income which accounts for 17.28% change. Track more Minerva Surgical, Inc. financial stats to get the full picture.
No, UTRS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, UTRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Minerva Surgical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
UTRS reached its all-time high on Oct 26, 2021 with the price of 207.4000 USD, and its all-time low was 0.0010 USD and was reached on Apr 25, 2024. View more price dynamics on UTRS chart.
See other stocks reaching their highest and lowest prices.
As of May 10, 2024, the company has 174.00 employees. See our rating of the largest employees — is Minerva Surgical, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Minerva Surgical, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Minerva Surgical, Inc. stock shows the strong sell signal. See more of Minerva Surgical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Minerva Surgical, Inc. EBITDA is ‪−25.35 M‬ USD, and current EBITDA margin is −56.79%. See more stats in Minerva Surgical, Inc. financial statements.